At UCB, we embrace the possibility to create a world free from the burden of immune-mediated inflammatory diseases.Relapsing and remitting in nature, these diseases place a huge strain on patients and their support systems. While there have been advancements in recent years, significant unmet needs remain. Our AmbitionWe believe that by harnessing data, technology and trailblazing science we can improve the lives of people living with these diseases. We can do this because:We are person-focused and people-drivenOur dedicated teams act with focus and care to create real improvements and value for the lives of the people we serve, now and into the future. We maintain deep connections with our partners, patients and scientific communities to drive innovation and co-create life-changing solutions. Our portfolio and talented teams are working to transform lives.We are unwavering in our purpose: delivering valuable health solutions We challenge accepted beliefs and boundaries to make a meaningful difference to people’s health, and to the well-being of the society in which we live. Each medicine in our immunology portfolio is designed to transform the lives of people with immune-mediated inflammatory diseases and deliver sustainable value to healthcare systems across the world.We are changing the future of immunology care through trailblazing science We are exploring new populations with unmet needs and solutions for hard-to-treat conditions, plus trailblazing approaches to move from symptomatic treatment to long-lasting drug-free remission.
